The stock of Baird Medical Investment Holdings Limited (BDMD) has gone down by -11.54% for the week, with a -9.07% drop in the past month and a -28.91% drop in the past quarter. The volatility ratio for the week is 21.71%, and the volatility levels for the past 30 days are 21.50% for BDMD. The simple moving average for the last 20 days is -21.60% for BDMD stock, with a simple moving average of -22.04% for the last 200 days.
Is It Worth Investing in Baird Medical Investment Holdings Limited (NASDAQ: BDMD) Right Now?
The stock has a 36-month beta value of -0.94.
The public float for BDMD is 12.66M, and at present, short sellers hold a 0.60% of that float. On July 04, 2025, the average trading volume of BDMD was 117.75K shares.
BDMD stock’s latest price update
Baird Medical Investment Holdings Limited (NASDAQ: BDMD) has seen a decline in its stock price by -0.51% in relation to its previous close of $3.93. However, the company has experienced a -11.54% decline in its stock price over the last five trading sessions. prnewswire.com reported 2025-05-19 that NEW YORK, May 19, 2025 /PRNewswire/ — Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place from May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.
BDMD Trading at -23.21% from the 50-Day Moving Average
After a stumble in the market that brought BDMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.08% of loss for the given period.
Volatility was left at 21.50%, however, over the last 30 days, the volatility rate increased by 21.71%, as shares sank -14.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.76% lower at present.
During the last 5 trading sessions, BDMD fell by -11.54%, in comparison to the 20-day moving average, which settled at $4.99. In addition, Baird Medical Investment Holdings Limited saw -64.19% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
N/A, the N/A of Baird Medical Investment Holdings Limited, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for BDMD
Current profitability levels for the company are sitting at:
- 0.31% for the present operating margin
- 0.87% for the gross margin
The net margin for Baird Medical Investment Holdings Limited stands at 0.28%. The total capital return value is set at 0.1%. Equity return is now at value -25.39%, with -14.19% for asset returns.
Based on Baird Medical Investment Holdings Limited (BDMD), the company’s capital structure generated 0.28 points at debt to capital in total, while cash flow to debt ratio is standing at -0.28.
Currently, EBITDA for the company is 12.85 million with net debt to EBITDA at 2.78. When we switch over and look at the enterprise to sales, we see a ratio of 11.7. The receivables turnover for the company is 0.38for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.
Conclusion
To sum up, Baird Medical Investment Holdings Limited (BDMD) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
